|
US4920132A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
US5324743A
(en)
|
1992-12-10 |
1994-06-28 |
Eli Lilly And Company |
Leukotriene B4 antagonists
|
|
GB2279659B
(en)
|
1993-07-05 |
1998-04-22 |
Merck Patent Gmbh |
Liquid crystalline material
|
|
AU727775B2
(en)
|
1996-01-17 |
2000-12-21 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
|
EP1011651B1
(en)
|
1996-02-02 |
2005-04-27 |
Merck & Co., Inc. |
Method of treating diabetes and related disease states
|
|
ATE262334T1
(de)
|
1996-02-02 |
2004-04-15 |
Merck & Co Inc |
Antidiabetisches mittel
|
|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
DE69720429T9
(de)
|
1996-02-02 |
2004-09-23 |
Merck & Co., Inc. |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
|
EP0888278B1
(en)
|
1996-02-02 |
2003-07-23 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
WO1998027974A1
(en)
|
1996-12-23 |
1998-07-02 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
AU749271B2
(en)
|
1997-07-01 |
2002-06-20 |
Agouron Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
PL338013A1
(en)
|
1997-07-16 |
2000-09-25 |
Novo Nordisk As |
Derivatives of condensed 1,2,4-thiadiazine, their production and application
|
|
AU8355998A
(en)
|
1997-07-24 |
1999-02-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Medicinal compositions with cholesterol-lowering effect
|
|
BR9814087A
(pt)
|
1997-10-17 |
2000-10-03 |
Aventis Pharm Prod Inc |
Processos para mediar a atividade do receptor de ppar-gama, e para tratar uma condição fisiológica em um paciente
|
|
CA2374263A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylether derivatives
|
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
AU7995300A
(en)
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
AU1303301A
(en)
|
1999-11-10 |
2001-06-06 |
Takeda Chemical Industries Ltd. |
Body weight gain inhibitors
|
|
PL355172A1
(en)
|
1999-11-11 |
2004-04-05 |
Eli Lilly And Company |
Oncolytic combinations for the treatment of cancer
|
|
AU784722B2
(en)
|
2000-02-18 |
2006-06-01 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
KR20020081424A
(ko)
|
2000-03-09 |
2002-10-26 |
아벤티스 파마 도이칠란트 게엠베하 |
Ｐｐａｒ 매개인자의 치료학적 용도
|
|
US6448293B1
(en)
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
FR2812876B1
(fr)
*
|
2000-08-08 |
2002-09-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
US6787552B2
(en)
|
2000-08-11 |
2004-09-07 |
Nippon Chemiphar Co., Ltd. |
PPAR delta activators
|
|
US6630504B2
(en)
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
|
GB0024361D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
|
JPWO2002046154A1
(ja)
|
2000-12-05 |
2004-04-08 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
GB0031107D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2433573A1
(en)
|
2000-12-28 |
2002-07-11 |
Takeda Chemical Industries, Ltd. |
Alkanoic acid derivatives, process for their production and use thereof
|
|
EP1357914A2
(en)
|
2001-02-02 |
2003-11-05 |
SmithKline Beecham Corporation |
Treatment of ppar mediated diseases
|
|
JP4157381B2
(ja)
|
2001-03-23 |
2008-10-01 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体の活性化剤
|
|
WO2002079162A1
(en)
|
2001-03-28 |
2002-10-10 |
Eisai Co., Ltd. |
Carboxylic acids
|
|
JPWO2002080899A1
(ja)
|
2001-03-30 |
2005-01-06 |
エーザイ株式会社 |
消化器疾患治療剤
|
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
|
WO2002098840A1
(en)
|
2001-06-04 |
2002-12-12 |
Eisai Co., Ltd. |
Carboxylic acid derivative and medicine comprising salt or ester of the same
|
|
FR2826574B1
(fr)
|
2001-06-29 |
2005-08-26 |
Oreal |
Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
|
|
BR0211414A
(pt)
*
|
2001-07-30 |
2004-08-17 |
Novo Nordisk As |
Composto, uso do mesmo, composição farmacêutica, e, métodos para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e de diabetes tipo i, diabetes tipo ii, tolerância à glicose, resistência à insulina ou obesidade prejudicadas
|
|
AU2002323776B2
(en)
|
2001-08-10 |
2008-07-31 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-responsive receptor Delta
|
|
WO2003016265A1
(en)
|
2001-08-17 |
2003-02-27 |
Eisai Co., Ltd. |
Cyclic compound and ppar agonist
|
|
EP1435946B8
(en)
|
2001-09-14 |
2013-12-18 |
Amgen Inc. |
Linked biaryl compounds
|
|
MXPA04003398A
(es)
|
2001-10-12 |
2004-11-22 |
Nippon Chemiphar Co |
Activador para el receptor o activado con el proliferador de peroxisoma.
|
|
JP2005505616A
(ja)
|
2001-10-17 |
2005-02-24 |
ノボ ノルディスク アクティーゼルスカブ |
ジカルボン酸誘導体、それらの調製、並びに治療上の用途
|
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
|
JP2003171275A
(ja)
|
2001-12-11 |
2003-06-17 |
Sumitomo Pharmaceut Co Ltd |
ＰＰＡＲδアゴニスト
|
|
US6648293B1
(en)
*
|
2001-12-20 |
2003-11-18 |
Braeside Plastics Corporation |
Foldable display container and method for assembling the same
|
|
ES2290439T3
(es)
|
2002-02-25 |
2008-02-16 |
Eli Lilly And Company |
Moduladores del receptor activado del proliferador de peroxisomas.
|
|
US7319104B2
(en)
|
2002-03-01 |
2008-01-15 |
Smithkline Beecham Corporation |
hPPARs activators
|
|
US6867224B2
(en)
|
2002-03-07 |
2005-03-15 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
US20030207924A1
(en)
|
2002-03-07 |
2003-11-06 |
Xue-Min Cheng |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6875780B2
(en)
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
|
GB0214149D0
(en)
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
AU2003281040A1
(en)
*
|
2002-07-10 |
2004-02-02 |
Sumitomo Pharmaceuticals Co., Ltd. |
Biaryl derivatives
|
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
AU2003287912A1
(en)
|
2002-12-20 |
2004-07-14 |
Novo Nordisk A/S |
Dicarboxylic acid derivatives as ppar-agonists
|
|
US7396850B2
(en)
|
2003-01-06 |
2008-07-08 |
Eli Lilly And Company |
Pyrazole derivative as PPAR modulator
|
|
DE10300099A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
JP2006518738A
(ja)
|
2003-02-12 |
2006-08-17 |
トランス テック ファーマ，インコーポレイテッド |
治療薬としての置換アゾール誘導体
|
|
CN1751037A
(zh)
|
2003-02-14 |
2006-03-22 |
伊莱利利公司 |
作为ppar调节剂的磺酰胺衍生物
|
|
JPWO2004080943A1
(ja)
|
2003-03-11 |
2006-06-08 |
小野薬品工業株式会社 |
シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
CA2518986A1
(en)
|
2003-03-13 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
Imino ether derivative compounds and drugs containing the compounds as the active ingredient
|
|
CA2521175A1
(en)
|
2003-04-07 |
2004-10-28 |
Kalypsys, Inc. |
Para-sulfonyl substituted phenyl compounds as modulators of ppars
|
|
KR100762762B1
(ko)
|
2003-04-17 |
2007-10-17 |
칼립시스, 인코포레이티드 |
Ｐｐａｒ의 조절인자로서의 아릴 화합물 및 신진대사장애의 치료 방법
|
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
MXPA05011536A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Acidos carboxilicos substituidos con fenilo como inhibidores de la proteina tirosina fosfatasa-1b.
|
|
US20070082907A1
(en)
|
2003-11-25 |
2007-04-12 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
WO2005097098A2
(en)
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
Use of ppr delta agonists for treating demyelinating diseases
|
|
AU2005230838A1
(en)
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
1,3,4-oxadiazol-2-ones as PPAR delta
|
|
NZ550857A
(en)
|
2004-04-01 |
2009-12-24 |
Aventis Pharma Inc |
1,3,4-oxadiazol-2-ones as PPAR delta modulators
|
|
DE602005024384D1
(de)
|
2004-05-05 |
2010-12-09 |
High Point Pharmaceuticals Llc |
Neue verbindungen, ihre herstellung und verwendung
|
|
BRPI0510024A
(pt)
|
2004-05-14 |
2007-09-25 |
Irm Llc |
compostos e composições como modulares de ppar
|
|
US7943612B2
(en)
|
2006-03-09 |
2011-05-17 |
High Point Pharmaceuticals, Llc |
Compounds that modulate PPAR activity, their preparation and use
|